carbidopa 31.25 MG / entacapone 200 MG / levodopa 125 MG Oral Tablet [Stalevo]
RxNorm concept 810087, branded drug (sbd). Prescribable name: Stalevo-125 31.25 MG / 125 MG / 200 MG Oral Tablet.
- RxCUI
- 810087
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/810087 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Carbidopa 31.25 MG / entacapone 200 MG / L-DOPA 125 MG Oral Tablet [Stalevo]; Stalevo 125 (carbidopa 31.25 MG / levodopa 125 MG / entacapone 200 MG) Oral Tablet; Stalevo 125 Oral Tablet
Related concepts
- entacapone 200 MG (SCDC, consists of)
- levodopa 125 MG (SCDC, consists of)
- carbidopa 31.25 MG (SCDC, consists of)
- carbidopa 31.25 MG / entacapone 200 MG / levodopa 125 MG [Stalevo] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Stalevo (BN, has ingredient)
- carbidopa 31.25 MG / entacapone 200 MG / levodopa 125 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 52427082701
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 810087 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/810087 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 810087. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.